Neurometrix Inc (NASDAQ: NURO) is having an incredibly strong day in the market today after announcing that it has been issued a new United States patent. Of course, this led to excitement among investors, causing the stock to climb, and prompting our partners at Trade Ideas to alert us to the gains. At the moment (10:31), NURO is trading at $3.58 per share after a gain of $0.33 per share or 10.24% thus far today.
NURO Gains On U.S. Patent Issuance
As mentioned above, Neurometrix is having a strong day in the market today after announcing that the United States Patent and Trademark Office has issued the company a new patent. The patent, number 9,675,801 covers the company’s novel mechanisms to help Quell® users safely obtain pain relief therapy over prolonged periods of time. In particular, the patent covers claims for technology to monitor the amount of time that Quell is worn both continually and in the aggregate, and to provide notifications to the user in order to maximize the safety associated with the treatment. In a statement, Shai N. Gozani, M.D., Ph.D., President and CEO at NURO, had the following to offer…
“We are pleased to have received this latest patent for Quell Wearable Pain Relief Technology(TM)… Quell is unique in the fact that the technology is designed for 24/7 therapy. We know from the Quell Health Cloud data that most of our users wear Quell for a substantial portion of the day to help them manage their chronic pain. The technology in this patent helps us ensure that this usage is both safe and effective.”
Stop wasting your time! Find winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will be keeping a close eye on NURO. In particular, we’re interested in following the company through turning this patent into a profit and are excited to see the technology the company comes up with next. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!